BridgeMD
Tests treatment safety and results for Cardiovascular Diseases
Official title BEhavioral and Adherence Model for Improving Quality, Health Outcomes and Cost-Effectiveness of healthcaRe
ClinicalTrials.gov ID: NCT06856902
What this study is testing
- What it's testing
- Lack of adherence to treatment is a widespread issue worldwide, which leads to higher healthcare utilisation rates and even premature death. While the level of adherence may differ based on the specific condition and treatment, studies estimate that approximately 50% of medications are not taken according to the prescribed instructions.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- Having the diagnosis of the pilot sites target groups described above as per clinical assessment or validated diagnosis criteria
- Having the age of the pilot sites target groups described above
- Having accepted to participate in the study and provided written informed consent
- Having the availability to participate on all study activities
You likely can't join if
- Individuals that do not fulfil ALL the inclusion criteria will be excluded to participate.
The study team makes the final eligibility decision.
Where it's taking place
- Düsseldorf, Germany
- Genova, Italy
- Veenendaal, Netherlands
- Lørenskog, Akershus, Norway
- Lisbon, Portugal
- Porto, Portugal
- Maribor, Slovenia
- Madrid, Spain
- Moshi, Tanzania
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Düsseldorf, Germany; Genova, Italy; Veenendaal, Netherlands; Lørenskog, Akershus, Norway; Lisbon, Portugal; Porto, Portugal and 3 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.